Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 09-2010 | 09-2009 | 12-2008 | 09-2008 | |
| Sales | 3 | 15 | 0 | 0 | 25 |
| Gross Profit | 3 | 15 | N/A | 20 | 25 |
| Operating Expenses | 1,891 | 1,904 | 4,911 | 0 | 5,380 |
| Operating Income | -1,888 | -1,890 | -4,911 | N/A | -5,355 |
| Interest Expense | 205 | 219 | 0 | 0 | 1,421 |
| Other Income | 874 | 207 | -272 | 0 | 6 |
| Pre-tax Income | -1,219 | -1,901 | -5,182 | 0 | -6,770 |
| Net Income Continuous | -1,219 | -1,901 | -5,182 | N/A | -6,770 |
| Net Income | $-1,219 | $-1,901 | $-5,182 | $N/A | $-6,770 |
| EPS Basic Total Ops | -0.31 | -0.47 | -0.24 | N/A | -0.21 |
| EPS Basic Continuous Ops | -0.13 | -0.29 | -0.16 | N/A | -0.21 |
| EPS Diluted Total Ops | -0.31 | -0.47 | -0.24 | N/A | -0.21 |
| EPS Diluted Continuous Ops | -0.13 | -0.29 | -0.16 | N/A | -0.21 |
| EBITDA(a) | $-1,854 | $-1,844 | $-4,865 | $40 | $-5,317 |